Talimogene Laherparepvec (T-VEC) for Breast Cancer Local Recurrence
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if talimogene laherparepvec can help to
control recurrent breast cancer. The safety of this drug will also be studied.